Derivative

Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc

Tuesday, July 27, 2021 - 2:31am

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Tuesday, July 27, 2021 - 2:30am

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Tuesday, July 27, 2021 - 2:30am

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

CAPSTEAD ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MDLA and Encourages Investors to Contact the Firm

Monday, July 26, 2021 - 7:26pm

On July 26, 2021, Capstead announced that it had entered into an agreement to be acquired by BSPRT in a cash and stock deal.

Key Points: 
  • On July 26, 2021, Capstead announced that it had entered into an agreement to be acquired by BSPRT in a cash and stock deal.
  • Bragar Eagel & Squire is concerned that Capsteads board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Capsteads stockholders.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

MEDALLIA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MDLA and Encourages Investors to Contact the Firm

Monday, July 26, 2021 - 7:23pm

On July 26, 2021, Medallia announced that it had entered into an agreement to be acquired by Thoma Bravo in a deal valued at approximately $6.4 billion.

Key Points: 
  • On July 26, 2021, Medallia announced that it had entered into an agreement to be acquired by Thoma Bravo in a deal valued at approximately $6.4 billion.
  • Pursuant to the merger agreement, Medallia stockholders will receive $34 in cash for each share of Medallia common stock owned.
  • Bragar Eagel & Squire is concerned that Medallias board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Saturday, July 24, 2021 - 2:10am

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Saturday, July 24, 2021 - 2:10am

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc

Saturday, July 24, 2021 - 2:10am

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

VEONEER ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of VNE and Encourages Investors to Contact the Firm

Friday, July 23, 2021 - 7:29pm

On July 22, 2021, Veoneer announced that it had entered into an agreement to be acquired by Magna in a deal valued at approximately $3.8 billion.

Key Points: 
  • On July 22, 2021, Veoneer announced that it had entered into an agreement to be acquired by Magna in a deal valued at approximately $3.8 billion.
  • Pursuant to the merger agreement, Veoneer stockholders will receive $31.25 in cash for each share of Veoneer common stock owned.
  • Bragar Eagel & Squire is concerned that Veoneers board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

THE NEW HOME COMPANY ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of NWHM and Encourages Investors to Contact the Firm

Friday, July 23, 2021 - 5:36pm

On July 23, 2021, NWHM announced that it had entered into an agreement to be acquired by Apollo in a deal valued at $338 million.

Key Points: 
  • On July 23, 2021, NWHM announced that it had entered into an agreement to be acquired by Apollo in a deal valued at $338 million.
  • Pursuant to the merger agreement, NWHM stockholders will receive $9.00 in cash for each share of NWHM common stock owned.
  • Bragar Eagel & Squire is concerned that NWHMs board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.